Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3U19AI118626-06S1

Grant search

Key facts

  • Disease

    Dengue
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $292,800
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Alessandro Sette
  • Research Location

    United States of America
  • Lead Research Institution

    LA JOLLA INSTITUTE FOR IMMUNOLOGY
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Our group has developed a set of data standards over the years to capture different aspects of immune profiling studies that enable the description of, for example, the immune exposure being studied (e.g. type and course of infection or vaccination) or the molecular markers measured in a cytometry assay and how they relate detected cells to specific cell types. These standards were primarily developed for the Human Immunology Project Consortium (HIPC), and were tailored to be interoperable with the ImmPort submission system, in which they have been adopted and are now used for all data submissions into ImmPort. For HIPC, these standards have enabled cross-center data analysis projects and method development. As part of this work, automated validation routines have been created that test ImmPort data submissions for their adherence to these data standards, which has enabled us to identify and correct issues in data submissions..